« Previous
Next »
Lung Cancer
Volume 47, Issue 1
, Pages
129-138
, January 2005
Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity
To access this article, please choose from the options below
☆ Part of this study has been presented at the 10th World Conference on Lung Cancer, 10–14 August 2003, Vancouver, Canada.
PII: S0169-5002(04)00258-2
doi: 10.1016/j.lungcan.2004.05.014
© 2004 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 47, Issue 1
, Pages
129-138
, January 2005
